The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades

Abstract Progress in the research and therapy of adult acute lymphoblastic leukemia (ALL) is accelerating. This analysis summarizes the data derived from the clinical trials conducted at MD Anderson between 1985 and 2022 across ALL subtypes. In Philadelphia chromosome-positive ALL, the addition of B...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Elias Jabbour, Nicholas J. Short, Nitin Jain, Fadi G. Haddad, Mary Alma Welch, Farhad Ravandi, Hagop Kantarjian
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	BMC 2023-03-01
Цуврал:	Journal of Hematology & Oncology
Нөхцлүүд:	Blinatumomab CAR T cell Chemotherapy-free Cure Evolution Inotuzumab
Онлайн хандалт:	https://doi.org/10.1186/s13045-023-01409-5
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!